Clinical use of flumazenil (Ro 15-1788) after endoscopic procedures

P. Spinelli, P. Pacilli, A. Sicignano

Research output: Contribution to journalArticlepeer-review


The patients were randomly divided into two groups; patients in group A (n = 29) received flumazenil i.v. (mean dosage = 0.6 mg) after the endoscopic procedure, patients in group B (n = 30) received placebo. After the administration of the trial drug the level of consciousness improved rapidly in patients of group A; it was already significantly different from group B after 5 minutes (p <0.001) and was maintained at 15, 30 and 60 minutes. Also the d deletion test showed a quicker improvement in psychomotor ability.

Original languageEnglish
Pages (from-to)86
Number of pages1
Issue number2
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Medicine (miscellaneous)


Dive into the research topics of 'Clinical use of flumazenil (Ro 15-1788) after endoscopic procedures'. Together they form a unique fingerprint.

Cite this